Transaction #1818 · Form 4 · 0001185185-25-001504
IGC Pharma, Inc. · Stock award · Options
IGC Pharma, Inc. · Transacted October 17, 2025 · Filed October 21, 2025
What does this filing report?
An SEC Form 4 filing for IGC Pharma, Inc. records a stock award involving Options on October 17, 2025. The reported quantity was 1,000,000. The filing date is October 21, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- IGC Pharma, Inc.
- Company CIK
- 0001326205
- Security type
- Derivative
- Acquisition type
- Stock award · Code A
- Quantity acquired
- 1,000,000
- Reported price
- 0
- Reference value
- 0
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 1,000,000
- Ownership description
- Not reported
- SEC acceptance time
- Oct 21, 2025, 8:44 AM EDT
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- GRIMALDI CLAUDIA ↗
PFO · Director
CIK 0001745853
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
This transaction is not mapped to a specific company listing.
Derivative terms
- Underlying security
- Common Stock
- Underlying quantity
- 1,000,000
- Conversion / exercise price
- Not reported
- Exercise date
- Not reported
- Expiration date
- March 31, 2038
Filing footnotes & remarks
- F1
- The Reporting Person was granted 1,000,000 options exercisable at $0.35, equally vesting over the next three years starting March 31st, 2026.
- F2
- The Reporting Person was granted Options subject to vesting according to specific milestones set by the Company's Board of Directors. The Options vest upon achievement of milestones. The exercise price is $0.35.
- F3
- Gift of shares of the Company's common stock to the reporting person's children who do not share the reporting person's household.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.